Stock PINC PREMIER, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Premier, Inc.

Equities

PINC

US74051N1028

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
20.96 USD +0.72% Intraday chart for Premier, Inc. -1.04% -6.26%
Apr. 26 Premier Maintains Quarterly Dividend at $0.21 Per Share, Payable June 15 to Stockholders of Record June 1 MT
Apr. 26 Premier, Inc. Declares Quarterly Cash Dividend on Class A Common Stock, Payable on June 15, 2024 CI

Valuation

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,418 2,454 4,254 4,210 3,294 2,511 - -
Enterprise Value (EV) 1 2,311 2,438 4,603 4,578 3,622 2,696 2,695 3,086
P/E ratio 21.6 x 5.26 x 15.7 x 16.3 x 18.8 x 14 x 12.5 x 11.1 x
Yield - - 2.18% 2.24% 3.04% 4.14% 4.27% 4.54%
Capitalization / Revenue 1.99 x 1.89 x 2.47 x 2.94 x 2.47 x 1.93 x 1.89 x 1.82 x
EV / Revenue 1.9 x 1.88 x 2.67 x 3.19 x 2.71 x 2.07 x 2.03 x 2.23 x
EV / EBITDA 4.12 x 4.32 x 9.73 x 9.18 x 7.25 x 6.42 x 6.44 x 7.44 x
EV / FCF 5.61 x 9.56 x 14.5 x 12.8 x 10 x 11.3 x 9.8 x 8.9 x
FCF Yield 17.8% 10.5% 6.92% 7.79% 10% 8.84% 10.2% 11.2%
Price to Book -5.74 x 30 x 1.91 x 1.77 x 1.42 x 1.17 x 1.08 x 1.02 x
Nbr of stocks (in thousands) 61,827 71,574 122,269 117,987 119,078 119,818 - -
Reference price 2 39.11 34.28 34.79 35.68 27.66 20.96 20.96 20.96
Announcement Date 8/20/19 8/25/20 8/17/21 8/16/22 8/22/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Junio 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,218 1,300 1,721 1,433 1,336 1,302 1,329 1,382
EBITDA 1 561 564 473.2 498.7 499.8 419.8 418.5 414.7
EBIT 1 368.5 373.6 256.9 260.1 242.1 244.8 249.9 242.8
Operating Margin 30.26% 28.75% 14.93% 18.15% 18.12% 18.81% 18.81% 17.57%
Earnings before Tax (EBT) 1 368.1 383.7 250.6 326.9 250 256.1 254.8 244.2
Net income 1 109.1 436.8 260.8 265.9 175 175.7 178.4 195.4
Net margin 8.96% 33.61% 15.15% 18.55% 13.1% 13.5% 13.42% 14.14%
EPS 2 1.810 6.516 2.220 2.190 1.470 1.498 1.672 1.893
Free Cash Flow 1 412 255.1 318.5 356.8 362.2 238.4 275 346.6
FCF margin 33.83% 19.63% 18.51% 24.9% 27.11% 18.32% 20.69% 25.09%
FCF Conversion (EBITDA) 73.43% 45.23% 67.31% 71.55% 72.48% 56.8% 65.71% 83.57%
FCF Conversion (Net income) 377.52% 58.41% 122.12% 134.2% 206.96% 135.69% 154.18% 177.43%
Dividend per Share 2 - - 0.7600 0.8000 0.8400 0.8673 0.8953 0.9512
Announcement Date 8/20/19 8/25/20 8/17/21 8/16/22 8/22/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 365.1 379.2 347.8 340.7 313.9 359.6 322.2 340.4 318.8 334.7 318.5 324.5 327.3 344.2 324.9
EBITDA 1 121.7 142 112.2 122.8 109.4 140.5 117.3 132.6 105.7 114.1 97.14 98.56 103.7 109.3 99.62
EBIT 1 72.28 77.96 56.82 53.01 58.51 88.17 62.57 32.85 58.97 65.69 53.18 54.13 56.28 61.15 52.16
Operating Margin 19.79% 20.56% 16.34% 15.56% 18.64% 24.52% 19.42% 9.65% 18.5% 19.62% 16.7% 16.68% 17.2% 17.77% 16.05%
Earnings before Tax (EBT) 1 140.3 83.6 53.76 49.2 61.73 88.14 65.88 34.25 56.35 72.14 50.65 49.57 57.44 62.32 53.41
Net income 1 122 75.54 38.42 29.9 42.72 64.05 46.8 21.46 44.76 54.3 40.26 40.2 42.14 46.08 40.15
Net margin 33.41% 19.92% 11.04% 8.78% 13.61% 17.81% 14.52% 6.31% 14.04% 16.22% 12.64% 12.39% 12.88% 13.39% 12.36%
EPS 2 0.9700 0.6200 0.3200 0.2500 0.3600 0.5400 0.3900 0.1800 0.3700 0.4500 0.3183 0.3567 0.3950 0.4525 0.4100
Dividend per Share 2 0.2000 0.2000 0.2000 0.2000 0.2100 0.2100 0.2100 0.2100 - - 0.2152 0.2152 0.2258 0.2258 0.2258
Announcement Date 11/2/21 2/1/22 5/3/22 8/16/22 11/1/22 2/7/23 5/2/23 8/22/23 11/7/23 2/5/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 349 368 329 185 184 575
Net Cash position 1 107 15.1 - - - - - -
Leverage (Debt/EBITDA) - - 0.7384 x 0.7383 x 0.6576 x 0.44 x 0.4392 x 1.385 x
Free Cash Flow 1 412 255 319 357 362 238 275 347
ROE (net income / shareholders' equity) 22.1% 19.1% 22% 13.5% 13.1% 10.8% 11.7% 11.7%
ROA (Net income/ Total Assets) 14.3% 12.2% 9.46% 8.8% 8.9% 7.13% 7.03% 7.4%
Assets 1 763.1 3,576 2,758 3,021 1,967 2,466 2,537 2,640
Book Value Per Share 2 -6.820 1.140 18.20 20.10 19.50 17.90 19.50 20.60
Cash Flow per Share 2 8.380 5.210 3.470 3.650 3.210 3.080 3.690 4.360
Capex 1 93.4 94.4 88.9 87.4 82.3 96.7 91.8 101
Capex / Sales 7.67% 7.26% 5.16% 6.1% 6.16% 7.43% 6.91% 7.28%
Announcement Date 8/20/19 8/25/20 8/17/21 8/16/22 8/22/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Premier, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
20.96 USD
Average target price
24.28 USD
Spread / Average Target
+15.83%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
PREMIER, INC. Stock Premier, Inc.
-6.26% 2.51B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. PINC Stock
  4. Financials Premier, Inc.